Trivaris approved for ocular inflammation

The FDA has approved Trivaris (triamcinolone acetonide injectable suspension, from Allergan), a synthetic glucocorticoid corticosteroid, for sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

For more information call (800) 433-8871 or visit www.allergan.com.